Related Experiment Videos
Pattern of endogenous lectins in a human epithelial tumor
Cancer Research
|January 1, 1985
Summary
Researchers identified novel carbohydrate-binding proteins, defined as lectins, in a human tumor. These lectins, which bind specific sugars, may play a role in cancer metastasis and offer potential for diagnosis and therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Malignant tumors involve complex cellular interactions.
- Endogenous carbohydrate-binding proteins (lectins) mediate cell recognition.
- Understanding tumor-specific lectins is crucial for cancer research.
Purpose of the Study:
- To isolate and characterize endogenous carbohydrate-binding proteins from a human malignant epithelial tumor.
- To investigate the potential role of these proteins in cancer biology.
- To explore their utility in diagnostics and therapeutics.
Main Methods:
- Fractionation of tumor extracts using affinity chromatography with various immobilized carbohydrates (lactose, melibiose, fucose, etc.).
- Isolation of Ca2+-dependent and Ca2+-independent proteins.
- Analysis of isolated proteins using gel electrophoresis.
- Agglutination assays with rabbit erythrocytes to confirm lectin activity.
Main Results:
- Several novel carbohydrate-binding proteins (lectins) were identified, including those binding lactose (Mr 64,000), melibiose (Mr 28,000), and fucose (Mr 62,000 and 70,000).
- Some isolated lectins were also found in normal, particularly embryonic, non-human vertebrate tissues.
- The identified proteins exhibited agglutinin activity but no enzymatic activity.
Conclusions:
- The study identified a complex pattern of endogenous lectins in a human tumor.
- These lectins may be involved in intercellular interactions during metastasis.
- The findings suggest potential applications for lectins in cancer diagnosis and therapy.